Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMapp

In the 1990s, monoclonal antibodies (mAbs) progressed from scientific tools to advanced therapeutics, particularly for the treatment of cancers and autoimmune and inflammatory disorders. In the arena of infectious disease, the inauguration of mAbs as a post-exposure treatment in humans against Ebola...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Antiviral research Ročník 226; s. 105873
Hlavní autoři:	Wong, Gary, Bienes, Kathrina Mae, XIII, Ara, Fausther-Bovendo, Hugues, Kobinger, Gary P.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.06.2024
Témata:	Africa, Western - epidemiology Animals Antibodies, Monoclonal - immunology Antibodies, Monoclonal - therapeutic use Antibodies, Neutralizing - immunology Antibodies, Neutralizing - therapeutic use Antibodies, Viral - immunology Antibodies, Viral - therapeutic use Disease Outbreaks Ebola Virus Ebolavirus - drug effects Ebolavirus - immunology EBOV Hemorrhagic Fever, Ebola - drug therapy Hemorrhagic Fever, Ebola - immunology Humans mAbs Monoclonal antibodies ZMapp Africa, Western Monoclonal antibodies EBOV Ebola Virus ZMapp mAbs
ISSN:	0166-3542, 1872-9096, 1872-9096
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!